13 results on '"Nikaido H"'
Search Results
2. Sensitivity of Escherichia coll to various β-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic β-lactamases: a quantitative predictive treatment.
- Author
-
Nikaido, H. and Normark, S.
- Subjects
ESCHERICHIA coli ,ESCHERICHIA ,ENTEROBACTERIACEAE ,GRAM-negative bacteria ,BETA lactam antibiotics ,LACTAMS - Abstract
In Gram-negative bacteria, β-lactam antibiotics must overcome two barriers, the outer membrane and the periplasmic β-lactamase, before they reach the targets of their action, penicillin-binding proteins. Although the barrier property of the outer membrane and catalytic property of the β-lactamases have been studied and their significance in creating p-lactam resistance emphasized, the interaction between these two barriers has not been treated quantitatively. Such treatment shows that the sensitivity, to a variety of β-lactams, of the Escherichia coli K-12 cells containing very different levels of chromosomally coded AmpC p-lactamase, or a plasmid-coded TEM-type p-lactamase, can be predicted rather accurately from the penetration rate through the outer membrane and the hydrolysis rate in the periplasm. We further propose a new parameter, ‘target access Index‘, which is a quantitative expression of the result of interaction between the two barriers, and reflects the probability of success for the antibiotic to reach the targets. [ABSTRACT FROM AUTHOR]
- Published
- 1987
- Full Text
- View/download PDF
3. Sensitivity of Escherichia coli to various ?-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic ?-lactamases: a quantitative predictive treatment
- Author
-
Nikaido, H., primary and Normark, S., additional
- Published
- 1987
- Full Text
- View/download PDF
4. Substrate path in the AcrB multidrug efflux pump of Escherichia coli.
- Author
-
Husain F and Nikaido H
- Subjects
- Bacterial Outer Membrane Proteins metabolism, Binding Sites, Cysteine metabolism, Escherichia coli metabolism, Escherichia coli Proteins genetics, Fluorescent Dyes metabolism, Membrane Transport Proteins metabolism, Multidrug Resistance-Associated Proteins genetics, Mutagenesis, Site-Directed, Protein Structure, Tertiary, Structure-Activity Relationship, Substrate Specificity, Escherichia coli genetics, Escherichia coli Proteins metabolism, Multidrug Resistance-Associated Proteins metabolism
- Abstract
A major tripartite multidrug efflux pump of Escherichia coli, AcrAB-TolC, confers resistance to a wide variety of compounds. The drug molecule is captured by AcrB probably from the periplasm or the periplasm/inner membrane interface, and is passed through AcrB and then TolC to the medium. Currently, there exist numerous crystallographic and mutation data concerning the regions of AcrB and its homologues that may interact with substrates. Starting with these data, we devised fluorescence assays in whole cells to determine the entire substrate path through AcrB. We tested 48 residues in AcrB along the predicted substrate path and 25 gave positive results, based on the covalent labelling of cysteine residues by a lipophilic dye-maleimide and the blocking of Nile red efflux by covalent labelling with bulky maleimide reagents. These residues are all located in the periplasmic domain, in regions we designate as the lower part of the large external cleft, the cleft itself, the crystallographically defined binding pocket, and the gate between the pocket and the funnel. Our observations suggest that the substrate is captured in the lower cleft region of AcrB, then transported through the binding pocket, the gate and finally to the AcrB funnel that connects AcrB to TolC., (© 2010 Blackwell Publishing Ltd.)
- Published
- 2010
- Full Text
- View/download PDF
5. Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides.
- Author
-
Bader MW, Navarre WW, Shiau W, Nikaido H, Frye JG, McClelland M, Fang FC, and Miller SI
- Subjects
- Alkaline Phosphatase metabolism, Anti-Bacterial Agents pharmacology, Bacterial Proteins biosynthesis, Bacterial Proteins genetics, Bacterial Proteins metabolism, Electrophoresis, Gel, Two-Dimensional, Gene Expression Profiling, Genes, Bacterial, Genes, Reporter genetics, Oxidative Stress genetics, Peptide Mapping, Polymyxins metabolism, Polymyxins pharmacology, Proteome analysis, Regulon physiology, Salmonella typhimurium drug effects, Sigma Factor genetics, Signal Transduction genetics, Signal Transduction physiology, beta-Galactosidase metabolism, Antimicrobial Cationic Peptides pharmacology, Drug Resistance, Bacterial, Gene Expression Regulation, Bacterial drug effects, Salmonella typhimurium genetics, Salmonella typhimurium pathogenicity, Virulence genetics
- Abstract
Cationic antimicrobial peptides (CAMP) represent a conserved and highly effective component of innate immunity. During infection, the Gram-negative pathogen Salmonella typhimurium induces different mechanisms of CAMP resistance that promote pathogenesis in animals. This study shows that exposure of S. typhimurium to sublethal concentrations of CAMP activates the PhoP/PhoQ and RpoS virulence regulons, while repressing the transcription of genes required for flagella synthesis and the invasion-associated type III secretion system. We further demonstrate that growth of S. typhimurium in low doses of the alpha-helical peptide C18G induces resistance to CAMP of different structural classes. Inducible resistance depends on the presence of PhoP, indicating that the PhoP/PhoQ system can sense sublethal concentrations of cationic antimicrobial peptides. Growth of S. typhimurium in the presence of CAMP also leads to RpoS-dependent protection against hydrogen peroxide. Because bacterial resistance to oxidative stress and CAMP are induced during infection of animals, CAMP may be an important signal recognized by bacteria on colonization of animal tissues.
- Published
- 2003
- Full Text
- View/download PDF
6. Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein.
- Author
-
Rosenberg EY, Bertenthal D, Nilles ML, Bertrand KP, and Nikaido H
- Subjects
- Anti-Bacterial Agents pharmacology, Bacterial Proteins genetics, Bile Acids and Salts metabolism, Carrier Proteins genetics, DNA-Binding Proteins genetics, Decanoates pharmacology, Drug Resistance, Bacterial, Escherichia coli genetics, Escherichia coli metabolism, Escherichia coli Proteins genetics, Fatty Acids metabolism, Lipoproteins genetics, Membrane Proteins genetics, Membrane Transport Proteins, Microbial Sensitivity Tests, Multidrug Resistance-Associated Proteins, Bacterial Proteins metabolism, Bile Acids and Salts pharmacology, Carrier Proteins metabolism, DNA-Binding Proteins metabolism, Escherichia coli drug effects, Escherichia coli Proteins metabolism, Fatty Acids pharmacology, Gene Expression Regulation, Bacterial, Lipoproteins metabolism, Membrane Proteins metabolism
- Abstract
AcrAB of Escherichia coli, an archetype among bacterial multidrug efflux pumps, exports an extremely wide range of substrates including solvents, dyes, detergents and antimicrobial agents. Its expression is regulated by three XylS/AraC family regulators, MarA, SoxS and Rob. Although MarA and SoxS regulation works by the alteration of their own expression levels, it was not known how Rob, which is constitutively expressed, exerts its regulatory action. We show here that the induction of the AcrAB efflux pump by decanoate and the more lipophilic unconjugated bile salts is mediated by Rob, and that the low-molecular-weight inducers specifically bind to the C-terminal, non-DNA-binding domain of Rob. Induction of Rob is not needed for induction of AcrAB, and we suggest that the inducers act by producing conformational alterations in pre-existing Rob, as was suggested recently (Rosner, Dangi, Gronenborn and Martin, J Bacteriol 184: 1407-1416, 2002). Decanoate and unconjugated bile salts, which are present in the normal habitat of E. coli, were further shown to make the bacteria more resistant to lipophilic antibiotics, at least in part because of the induction of the AcrAB efflux pump. Thus, it is likely that E. coli is protecting itself by the Rob-mediated upregulation of AcrAB against the harmful effects of bile salts and fatty acids in the intestinal tract.
- Published
- 2003
- Full Text
- View/download PDF
7. Multidrug resistance mechanisms: drug efflux across two membranes.
- Author
-
Zgurskaya HI and Nikaido H
- Subjects
- Bacterial Outer Membrane Proteins metabolism, Cell Membrane metabolism, Gram-Negative Bacteria metabolism, Gram-Negative Bacteria physiology, Periplasm metabolism, Carrier Proteins metabolism, Drug Resistance, Microbial physiology, Drug Resistance, Multiple physiology, Gram-Negative Bacteria drug effects, Ion Channels metabolism
- Abstract
A set of multidrug efflux systems enables Gram-negative bacteria to survive in a hostile environment. This review focuses on the structural features and the mechanism of major efflux pumps of Gram-negative bacteria, which expel from the cells a remarkably broad range of antimicrobial compounds and produce the characteristic intrinsic resistance of these bacteria to antibiotics, detergents, dyes and organic solvents. Each efflux pump consists of three components: the inner membrane transporter, the outer membrane channel and the periplasmic lipoprotein. Similar to the multidrug transporters from eukaryotic cells and Gram-positive bacteria, the inner membrane transporters from Gram-negative bacteria recognize and expel their substrates often from within the phospholipid bilayer. This efflux occurs without drug accumulation in the periplasm, implying that substrates are pumped out across the two membranes directly into the medium. Recent data suggest that the molecular mechanism of the drug extrusion across a two-membrane envelope of Gram-negative bacteria may involve the formation of the membrane adhesion sites between the inner and the outer membranes. The periplasmic components of these pumps are proposed to cause a close membrane apposition as the complexes are assembled for the transport.
- Published
- 2000
- Full Text
- View/download PDF
8. The local repressor AcrR plays a modulating role in the regulation of acrAB genes of Escherichia coli by global stress signals.
- Author
-
Ma D, Alberti M, Lynch C, Nikaido H, and Hearst JE
- Subjects
- ATP Binding Cassette Transporter, Subfamily B, Member 1 metabolism, Bacterial Proteins genetics, Bacterial Proteins metabolism, Base Sequence, DNA Primers chemistry, Drug Resistance genetics, Escherichia coli Proteins metabolism, Gene Expression Regulation, Bacterial genetics, Genes, Reporter genetics, Lac Operon genetics, Models, Biological, Molecular Sequence Data, Mutation genetics, Repressor Proteins metabolism, Transcription, Genetic genetics, Escherichia coli metabolism, Escherichia coli Proteins genetics, Repressor Proteins genetics
- Abstract
Genes acrAB encode a multidrug efflux pump in Escherichia coli. We have previously reported that transcription of acrAB is increased under general stress conditions (i.e. 4% ethanol, 0.5 M NaCl, and the stationary phase in Luria-Bertani medium). In this study, lacZ transcriptional fusions and an in vitro gel mobility shift assay have been utilized to study the mechanisms governing the regulation of acrAB. We found that a closely linked gene, acrR, encoded a repressor of acrAB. Nevertheless, the general stress conditions increased transcription of acrAB in the absence of functional AcrR, and such conditions surprisingly increased the transcription of acrR even more strongly than that of acrAB. These results suggest that the general-stress-induced transcription of acrAB is primarily mediated by global regulatory pathway(s), and that one major role of AcrR is to function as a specific secondary modulator to fine tune the level of acrAB transcription and to prevent the unwanted overexpression of acrAB. To our knowledge, this represents a novel mechanism of regulating gene expression in E. coli. Evidence also suggests that the up-regulation of acrAB expression under general stress conditions is not likely to be mediated by the known global regulators, such as MarA or SoxS, although elevated levels of these proteins were shown to increase the transcription of acrAB.
- Published
- 1996
- Full Text
- View/download PDF
9. Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli.
- Author
-
Ma D, Cook DN, Alberti M, Pon NG, Nikaido H, and Hearst JE
- Subjects
- Acriflavine pharmacology, Anti-Bacterial Agents pharmacology, Bacterial Proteins biosynthesis, Bacterial Proteins genetics, Biological Transport, Active, Cell Membrane Permeability, Cholic Acids pharmacology, Drug Resistance, Multiple genetics, Escherichia coli drug effects, Escherichia coli growth & development, Escherichia coli metabolism, Fatty Acids pharmacology, Lipoproteins biosynthesis, Lipoproteins genetics, Membrane Proteins biosynthesis, Membrane Proteins genetics, Membrane Transport Proteins, Microbial Sensitivity Tests, Multidrug Resistance-Associated Proteins, Mutagenesis, Insertional, Operon, Sodium Dodecyl Sulfate pharmacology, Time Factors, ATP Binding Cassette Transporter, Subfamily B, Member 1, Bacterial Proteins physiology, Carrier Proteins, Escherichia coli genetics, Escherichia coli Proteins, Gene Expression Regulation, Bacterial, Lipoproteins physiology, Membrane Proteins physiology
- Abstract
Defined mutations of acrA or acrB (formerly acrE) genes increased the susceptibility of Escherichia coli to a range of small inhibitor molecules. Deletion of acrAB increased susceptibility to cephalothin and cephaloridine, but the permeability of these beta-lactams across the outer membrane was not increased. This finding is inconsistent with the earlier hypothesis that acrAB mutations increase drug susceptibility by increasing the permeability of the outer membrane, and supports our model that acrAB codes for a multi-drug efflux pump. The natural environment of an enteric bacterium such as E. coli is enriched in bile salts and fatty acids. An acrAB deletion mutant was found to be hypersusceptible to bile salts and to decanoate. In addition, acrAB expression was elevated by growth in 5 mM decanoate. These results suggest that one major physiological function of AcrAB is to protect E. coli against these and other hydrophobic inhibitors. Transcription of acrAB is increased by other stress conditions including 4% ethanol, 0.5 M NaCl, and stationary phase in Luria-Bertani medium. Finally, acrAB expression was shown to be increased in mar (multiple-antibiotic-resistant) mutants.
- Published
- 1995
- Full Text
- View/download PDF
10. Physical organization of lipids in the cell wall of Mycobacterium chelonae.
- Author
-
Nikaido H, Kim SH, and Rosenberg EY
- Subjects
- Cell Wall metabolism, Cephalosporins metabolism, Models, Biological, Mycolic Acids metabolism, Nontuberculous Mycobacteria metabolism, Permeability, X-Ray Diffraction, Cell Wall ultrastructure, Lipids chemistry, Nontuberculous Mycobacteria ultrastructure
- Abstract
Mycobacterial cell wall functions as an effective permeability barrier, making these bacteria resistant to most antibacterial agents. It has been assumed that this low permeability was due to the presence of a large amount of unusual lipids in the cell wall, but it was not known how these lipids are able to produce such an exceptional barrier. We report here the first experimental evidence on the physical arrangement of these lipids based on X-ray diffraction studies of purified Mycobacterium chelonae cell wall, a result suggesting that the hydrocarbon chains of the cell-wall lipids are arranged predominantly in a direction perpendicular to the cell wall surface, probably producing an asymmetric bilayer structure.
- Published
- 1993
- Full Text
- View/download PDF
11. Interaction between maltose-binding protein and the membrane-associated maltose transporter complex in Escherichia coli.
- Author
-
Dean DA, Hor LI, Shuman HA, and Nikaido H
- Subjects
- Bacterial Proteins drug effects, Bacterial Proteins genetics, Biological Transport, Carrier Proteins drug effects, Carrier Proteins genetics, Cell Membrane metabolism, Drug Combinations, Escherichia coli genetics, Kinetics, Maltose genetics, Maltose-Binding Proteins, Membrane Proteins drug effects, Membrane Proteins genetics, Mutation, ATP-Binding Cassette Transporters, Bacterial Proteins metabolism, Carrier Proteins metabolism, Escherichia coli metabolism, Escherichia coli Proteins, Maltose metabolism, Membrane Proteins metabolism, Monosaccharide Transport Proteins, Periplasmic Binding Proteins
- Abstract
Active transport of maltose in Escherichia coli requires the presence of both maltose-binding protein (MBP) in the periplasm and a complex of MalF, MalG, and MalK proteins (FGK2) located in the cytoplasmic membrane. Earlier, mutants in malF or malG were isolated that are able to grow on maltose in the complete absence of MBP. When the wild-type malE+ allele, coding for MBP, was introduced into these MBP-independent mutants, they frequently lost their ability to grow on maltose. Furthermore, starting from these Mal- strains, Mal+ secondary mutants that contained suppressor mutations in malE were isolated. In this study, we examined the interaction of wild-type and mutant MBPs with wild-type and mutant FGK2 complexes by using right-side-out membrane vesicles. The vesicles from a MBP-independent mutant (malG511) transported maltose in the absence of MBP, with Km and Vmax values similar to those found in intact cells. However, addition of wild-type MBP to these mutant vesicles produced unexpected responses. Although malE+ malG511 cells could not utilize maltose, wild-type MBP at low concentrations stimulated the maltose uptake by malG511 vesicles. At higher concentrations of the wild-type MBP and maltose, however, maltose transport into malG511 vesicles became severely inhibited. This behaviour of the vesicles was also reflected in the phenotype of malE+ malG511 cells, which were found to be capable of transporting maltose from a low external concentration (1 microM), but apparently not from millimolar concentrations present in maltose minimal medium. We found that the mutant FGK2 complex, containing MalG511, had a much higher apparent affinity towards the wild-type MBP than did the wild-type FGK2 complex.(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1992
- Full Text
- View/download PDF
12. Outer membranes of gram-negative bacteria are permeable to steroid probes.
- Author
-
Plésiat P and Nikaido H
- Subjects
- Bacterial Outer Membrane Proteins metabolism, Bacterial Proteins metabolism, Cell Membrane Permeability, Diffusion, Lipopolysaccharides genetics, Lipopolysaccharides metabolism, Membrane Lipids metabolism, Oxidoreductases metabolism, Pseudomonas enzymology, Pseudomonas genetics, Species Specificity, Cell Membrane metabolism, Gram-Negative Bacteria metabolism, Steroids metabolism
- Abstract
The permeability of bacterial outer membranes was assayed by coupling the influx of highly hydrophobic probes, 3-oxosteroids, with their subsequent oxidation catalysed by 3-oxosteroid delta 1-dehydrogenase, expressed from a gene cloned from Pseudomonas testosteroni. In Salmonella typhimurium producing wild-type lipopolysaccharide, the permeability coefficients for uncharged steroids were 0.45 to 1 x 10(-5) cm s-1, and the diffusion appeared to occur mainly through the lipid bilayer domains of the outer membrane. These rates are one or two magnitudes lower than that expected for their diffusion through the usual biological membranes. The permeation rates were markedly increased (up to 100 times) when the lipopolysaccharide leaflet was perturbed either by adding deacylpolymyxin or by introducing mutations leading to the production of deep rough lipopolysaccharides. An amphiphilic, negatively charged probe, testosterone hemisuccinate, penetrated much more slowly than the uncharged steroids. Study of various Gram-negative species revealed that P. testosteroni, Pseudomonas acidovorans, and Acinetobacter calcoaceticus showed higher outer membrane permeability to steroid probes and higher susceptibility to hydrophobic agents such as fusidic acid, novobiocin and crystal violet relative to S. typhimurium and Escherichia coli.
- Published
- 1992
- Full Text
- View/download PDF
13. Sensitivity of Escherichia coli to various beta-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic beta-lactamases: a quantitative predictive treatment.
- Author
-
Nikaido H and Normark S
- Subjects
- Anti-Bacterial Agents metabolism, Bacterial Outer Membrane Proteins metabolism, Cell Membrane Permeability, Escherichia coli metabolism, Kinetics, Microbial Sensitivity Tests, beta-Lactams, Anti-Bacterial Agents pharmacology, Escherichia coli drug effects, beta-Lactamases metabolism
- Abstract
In Gram-negative bacteria, beta-lactam antibiotics must overcome two barriers, the outer membrane and the periplasmic beta-lactamase, before they reach the targets of their action, penicillin-binding proteins. Although the barrier property of the outer membrane and catalytic property of the beta-lactamases have been studied and their significance in creating beta-lactam resistance emphasized, the interaction between these two barriers has not been treated quantitatively. Such treatment shows that the sensitivity, to a variety of beta-lactams, of the Escherichia coli K-12 cells containing very different levels of chromosomally coded AmpC beta-lactamase, or a plasmid-coded TEM-type beta-lactamase, can be predicted rather accurately from the penetration rate through the outer membrane and the hydrolysis rate in the periplasm. We further propose a new parameter, 'target access index', which is a quantitative expression of the result of interaction between the two barriers, and reflects the probability of success for the antibiotic to reach the targets.
- Published
- 1987
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.